Related Experiment Video
Updated: Sep 28, 2025

07:13
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
635
Correction to: Protease-stable DARPins as promising oral therapeutics
Rudo A Simeon1, Yu Zeng1, Vikas Chonira1
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, 8847 Riverside Pkwy, Bryan, TX 77807, USA.
Protein Engineering, Design & Selection : PEDS
|April 3, 2022
Abstract
No abstract available in PubMed .

